{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:41:22Z","timestamp":1790606482792,"version":"4.1.0"},"reference-count":62,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,1,22]]},"DOI":"10.18632\/aging.102699","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:49:01Z","timestamp":1579740541000},"page":"1545-1562","source":"Crossref","is-referenced-by-count":56,"title":["Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis"],"prefix":"10.18632","volume":"12","author":[{"given":"Yuxiu","family":"Xie","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"},{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingli","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/joim.12446","article-title":"Benefits and risks of antihypertensive medications in the elderly.","volume":"27","author":"Harvey","year":"2015","journal-title":"J Intern Med"},{"key":"2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10549-013-2654-3","article-title":"Therapeutic effect of \u03b2-blockers in triple-negative breast cancer postmenopausal women.","volume":"14","author":"Gandini","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/labinvest.3700504","article-title":"Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis.","volume":"8","author":"Umemura","year":"2007","journal-title":"Lab Invest"},{"key":"4","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1158\/1535-7163.MCT-10-0535","article-title":"Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer.","volume":"9","author":"Oya","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2010.11.002","article-title":"Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer.","volume":"7","author":"Oya","year":"2011","journal-title":"Urology"},{"key":"6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3892\/etm_00000046","article-title":"Telmisartan inhibits human urological cancer cell growth through early apoptosis.","volume":"1","author":"Yoshimura","year":"2010","journal-title":"Exp Ther Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ki.1996.426","article-title":"Thiazide treatment of rats provokes apoptosis in distal tubule cells.","volume":"5","author":"Kaissling","year":"1996","journal-title":"Kidney Int"},{"key":"8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.","volume":"36","author":"Pocock","year":"2003","journal-title":"Lancet"},{"key":"9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.","volume":"1","author":"Fang","year":"2010","journal-title":"Lancet Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","article-title":"Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.","volume":"1","author":"Messerli","year":"2011","journal-title":"Lancet Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s40264-018-0644-4","article-title":"The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies.","volume":"4","author":"Matok","year":"2018","journal-title":"Drug Saf"},{"key":"12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/CEJ.0000000000000269","article-title":"The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis.","volume":"2","author":"Seong","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"13","doi-asserted-by":"publisher","first-page":"e3600","DOI":"10.1097\/MD.0000000000003600","article-title":"Angiotensin II receptor blockers and cancer risk a meta-analysis of randomized controlled trials.","volume":"9","author":"Yi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"6","author":"Jemal","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"15","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018.","volume":"7","author":"Catto","year":"2018","journal-title":"Eur Urol"},{"key":"16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ucl.2004.01.004","article-title":"Risk factors for adult renal cell carcinoma.","volume":"3","author":"Vidal-Trecan","year":"2004","journal-title":"Urol Clin North Am"},{"key":"17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/pds.1656","article-title":"Long-term use of antihypertensive drugs and risk of cancer.","volume":"1","author":"Suissa","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"18","first-page":"327","article-title":"Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension.","volume":"4","author":"Fraumeni","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/HJH.0000000000001130","article-title":"Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control study.","volume":"3","author":"Kao","year":"2017","journal-title":"J Hypertens"},{"key":"20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10552-017-0857-3","article-title":"Antihypertensive medication use and risk of renal cell carcinoma.","volume":"2","author":"Purdue","year":"2017","journal-title":"Cancer Causes Control"},{"key":"21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF00052431","article-title":"Increased risk of renal cell cancer among women using diuretics in the United States.","volume":"4","author":"Low","year":"1993","journal-title":"Cancer Causes Control"},{"key":"22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/CEJ.0000000000000419","article-title":"Bladder cancer risk in users of selected drugs for cardiovascular disease prevention.","volume":"2","author":"Tavani","year":"2019","journal-title":"Eur J Cancer Prev"},{"key":"23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF01804982","article-title":"Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA).","volume":"5","author":"Quesenberry","year":"1994","journal-title":"Cancer Causes Control"},{"key":"24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00004872-199816010-00017","article-title":"Cancer risk of hypertensive patients taking calcium antagonists.","volume":"1","author":"Lever","year":"1998","journal-title":"J Hypertens"},{"key":"25","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/carcin\/bgq173","article-title":"Hypertension, diuretics and antihypertensives in relation to bladder cancer.","volume":"3","author":"Gago-Dominguez","year":"2010","journal-title":"Carcinogenesis"},{"key":"26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF00053150","article-title":"Risk factors for renal cell carcinoma: results of a population-based case-control study.","volume":"4","author":"Darlington","year":"1993","journal-title":"Cancer Causes Control"},{"key":"27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF00146885","article-title":"Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors.","volume":"3","author":"Stewart","year":"1992","journal-title":"Cancer Causes Control"},{"key":"28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ijc.2910630212","article-title":"International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension.","volume":"6","author":"Adami","year":"1995","journal-title":"Int J Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/ije\/23.5.923","article-title":"Risk factors for renal cell carcinoma in Denmark: role of medication and medical history.","volume":"2","author":"Olsen","year":"1994","journal-title":"Int J Epidemiol"},{"key":"30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jama.279.13.1000","article-title":"Calcium channel blockers and the risk of cancer.","volume":"27","author":"Shapiro","year":"1998","journal-title":"JAMA"},{"key":"31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/oxfordjournals.aje.a009848","article-title":"Hypertension, antihypertensive medication use, and risk of renal cell carcinoma.","volume":"14","author":"Barlow","year":"1999","journal-title":"Am J Epidemiol"},{"key":"32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/oxfordjournals.aje.a117328","article-title":"Use of diuretics and other antihypertensive medications in relation to the risk of renal cell cancer.","volume":"14","author":"White","year":"1994","journal-title":"Am J Epidemiol"},{"key":"33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/jnci\/77.2.351","article-title":"Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma.","volume":"7","author":"Henderson","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"34","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/bjc.1998.248","article-title":"Hypertension, obesity and their medications in relation to renal cell carcinoma.","volume":"7","author":"Yu","year":"1998","journal-title":"Br J Cancer"},{"key":"35","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0735-1097(98)00008-4","article-title":"Calcium channel blocking agents and risk of cancer in patients with coronary heart disease.","volume":"3","author":"Goldbourt","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"36","doi-asserted-by":"publisher","first-page":"e1097","DOI":"10.1097\/MD.0000000000001097","article-title":"Propranolol Reduces Cancer Risk: A Population-Based Cohort Study.","volume":"9","author":"Kao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"37","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10552-005-0349-8","article-title":"A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States).","volume":"1","author":"Curhan","year":"2005","journal-title":"Cancer Causes Control"},{"key":"38","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/ije\/19.4.832","article-title":"Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-Day Adventists.","volume":"1","author":"Beeson","year":"1990","journal-title":"Int J Epidemiol"},{"key":"39","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/sj.bjc.6602490","article-title":"A cohort study of antihypertensive treatments and risk of renal cell cancer.","volume":"9","author":"Friis","year":"2005","journal-title":"Br J Cancer"},{"key":"40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/oxfordjournals.aje.a009157","article-title":"Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer.","volume":"14","author":"Thun","year":"1997","journal-title":"Am J Epidemiol"},{"key":"41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13300-016-0152-4","article-title":"Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study.","volume":"7","author":"Morden","year":"2016","journal-title":"Diabetes Ther"},{"key":"42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00001648-199701000-00005","article-title":"Nutrition and other risk factors for renal cell carcinoma in postmenopausal women.","volume":"8","author":"Potter","year":"1997","journal-title":"Epidemiology"},{"key":"43","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1097\/01.hjh.0000186023.74245.48","article-title":"Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study.","volume":"2","author":"van den Brandt","year":"2005","journal-title":"J Hypertens"},{"key":"44","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/aje\/kwm170","article-title":"Risk factors for renal cell cancer: the multiethnic cohort.","volume":"16","author":"Henderson","year":"2007","journal-title":"Am J Epidemiol"},{"key":"45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.amjcard.2011.09.050","article-title":"Candesartan-based therapy and risk of cancer in patients with systemic hypertension (Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] substudy).","volume":"10","author":"Hagiwara","year":"2012","journal-title":"Am J Cardiol"},{"key":"46","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00125-011-2171-z","article-title":"Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.","volume":"5","author":"Tseng","year":"2011","journal-title":"Diabetologia"},{"key":"47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/aje\/kwm321","article-title":"Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition.","volume":"16","author":"Sieri","year":"2008","journal-title":"Am J Epidemiol"},{"key":"48","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1096\/fj.03-0129com","article-title":"Differential regulation of in vivo angiogenesis by angiotensin II receptors.","volume":"1","author":"Schirner","year":"2003","journal-title":"FASEB J"},{"key":"49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1600-0404.1989.tb03731.x","article-title":"Inhibitory effect of calcium channel blockers on proliferation of human glioma cells in vitro.","volume":"7","author":"Pawlikowski","year":"1989","journal-title":"Acta Neurol Scand"},{"key":"50","first-page":"1090","article-title":"Does diuretic therapy increase the risk of renal cell carcinoma?","volume":"8","author":"Goldbourt","year":"1999","journal-title":"Am J Cardiol"},{"key":"51","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJM200011023431804","article-title":"Obesity, hypertension, and the risk of kidney cancer in men.","volume":"34","author":"J\u00e4rvholm","year":"2000","journal-title":"N Engl J Med"},{"key":"52","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1053\/euhj.1999.1534","article-title":"Diuretic therapy and renal cell carcinoma\u2014another controversy?","volume":"2","author":"Messerli","year":"1999","journal-title":"Eur Heart J"},{"key":"53","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1172\/JCI601","article-title":"Estradiol enhances thiazide-sensitive NaCl cotransporter density in the apical plasma membrane of the distal convoluted tubule in ovariectomized rats.","volume":"10","author":"Hebert","year":"1998","journal-title":"J Clin Invest"},{"key":"54","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Group","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/00001648-199305000-00005","article-title":"Meta-analysis of epidemiologic dose-response data.","volume":"4","author":"Greenland","year":"1993","journal-title":"Epidemiology"},{"key":"56","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","article-title":"Methods for trend estimation from summarized dose-response data, with applications to meta-analysis.","volume":"13","author":"Longnecker","year":"1992","journal-title":"Am J Epidemiol"},{"key":"57","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/sim.4780080504","article-title":"Flexible regression models with cubic splines.","volume":"8","author":"Simon","year":"1989","journal-title":"Stat Med"},{"key":"58","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/jnci\/80.15.1198","article-title":"Regression models in clinical studies: determining relationships between predictors and response.","volume":"8","author":"Pollock","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"59","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/biomet\/37.3-4.256","article-title":"The comparison of percentages in matched samples.","volume":"3","author":"Cochran","year":"1950","journal-title":"Biometrika"},{"key":"60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"32","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"61","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"Laird","year":"1986","journal-title":"Control Clin Trials"},{"key":"62","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"31","author":"Minder","year":"1997","journal-title":"BMJ"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:00:23Z","timestamp":1599076823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1,31]]}},"alternative-id":["102699","31968309"],"URL":"https:\/\/doi.org\/10.18632\/aging.102699","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]}}}